Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–88 of 88 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Peripheral Access Clear all
No Longer Available No phase listed Expanded access

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

NCT05095116
View directory record Official record
Conditions
Eosinophilic Esophagitis
Interventions
APT-1011 3 mg HS
Drug
Lead sponsor
Ellodi Pharmaceuticals, LP
Industry
Eligibility
12 Years and older
U.S. locations
35
States / cities
Tucson, Arizona • North Little Rock, Arkansas • Camarillo, California + 31 more
Source: ClinicalTrials.gov public record
Updated Oct 3, 2025 · Synced Oct 30, 2026, 4:53 AM EDT
Available No phase listed Expanded access

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

NCT03145545
View directory record Official record
Conditions
Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies
Interventions
Apha/beta T and CD19+ cell depletion using CliniMACS device
Device
Lead sponsor
Children's Hospital of Philadelphia
Other
Eligibility
1 Month and older
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jul 8, 2026 · Synced Oct 30, 2026, 4:53 AM EDT
Withdrawn Not applicable Interventional

Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement

NCT01870661
View directory record Official record
Conditions
Need for IV Access
Interventions
Long axis IV placement with ultrasound, Short axis IV placement with ultrasound
Device
Lead sponsor
Beth Israel Medical Center
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2014
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jun 25, 2014 · Synced Oct 30, 2026, 4:53 AM EDT
Completed Not applicable Interventional

Ultrasound Assisted Peripheral Venous Access in Young Children

NCT00557154
View directory record Official record
Conditions
Catheterization, Peripheral
Interventions
ultrasound, standard technique for venipuncture
Device
Lead sponsor
University of California, Davis
Other
Eligibility
Up to 7 Years
Enrollment
44 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2003 – 2004
U.S. locations
1
States / cities
Sacramento, California
Source: ClinicalTrials.gov public record
Updated Feb 15, 2017 · Synced Oct 30, 2026, 4:53 AM EDT
No Longer Available No phase listed Expanded access

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

NCT02075177
View directory record Official record
Conditions
Recurrent Neuroblastoma, Neuroblastoma
Interventions
Fenretinide Lym-X-Sorb Oral Powder, Ketoconazole
Drug
Lead sponsor
South Plains Oncology Consortium
Network
Eligibility
Not listed
U.S. locations
3
States / cities
Oklahoma City, Oklahoma • Dallas, Texas • Fort Worth, Texas
Source: ClinicalTrials.gov public record
Updated Mar 21, 2022 · Synced Oct 30, 2026, 4:53 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Effectiveness of External Vibration for Pain Relief During Intravenous Access in Adult Patients

NCT03619135
View directory record Official record
Conditions
Pain Management, Anxiety
Interventions
Buzzy, Placebo
Device · Other
Lead sponsor
Kyle Stein
Other
Eligibility
18 Years to 40 Years
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016 – 2017
U.S. locations
1
States / cities
Iowa City, Iowa
Source: ClinicalTrials.gov public record
Updated Feb 5, 2019 · Synced Oct 30, 2026, 4:53 AM EDT
No Longer Available No phase listed Expanded access

Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair

NCT02480777
View directory record Official record
Conditions
Sciatic Nerve Injury
Interventions
Autologous Human Schwann cells
Biological
Lead sponsor
W. Dalton Dietrich
Other
Eligibility
18 Years and older
U.S. locations
1
States / cities
Miami, Florida
Source: ClinicalTrials.gov public record
Updated Mar 5, 2019 · Synced Oct 30, 2026, 4:53 AM EDT
Available No phase listed Expanded access

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

NCT03015844
View directory record Official record
Conditions
Neuroblastoma, Pheochromocytoma
Interventions
131-I-meta-iodobenzylguanidine
Drug
Lead sponsor
Northwell Health
Other
Eligibility
365 Days to 29 Years
U.S. locations
1
States / cities
New Hyde Park, New York
Source: ClinicalTrials.gov public record
Updated Aug 6, 2026 · Synced Oct 30, 2026, 4:53 AM EDT
Completed Not applicable Interventional Results available

Femoral Arterial Access With Ultrasound Trial

NCT00667381
View directory record Official record
Conditions
Vascular Access Complications, Cardiac Catheterization, Peripheral Vascular Disease
Interventions
Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine)
Device
Lead sponsor
University of California, Irvine
Other
Eligibility
18 Years and older
Enrollment
1,014 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2009
U.S. locations
4
States / cities
Long Beach, California • Orange, California • Oklahoma City, Oklahoma
Source: ClinicalTrials.gov public record
Updated Nov 16, 2010 · Synced Oct 30, 2026, 4:53 AM EDT
Recruiting Early Phase 1 Interventional

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

NCT02356653
View directory record Official record
Conditions
Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes, Immunodeficiencies, Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome
Interventions
Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
Biological
Lead sponsor
Children's Hospital of Philadelphia
Other
Eligibility
Up to 30 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2030
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Feb 20, 2026 · Synced Oct 30, 2026, 4:53 AM EDT
Withdrawn Not applicable Interventional

Evaluating the Role of the Guidewire in Peripheral Intravenous Access

NCT04949854
View directory record Official record
Conditions
Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
Interventions
B.Braun 6.35 cm 20 Gauge ultralong intravenous catheter, B.D Accucath 5.71 cm 20 Gauge ultralong intravenous catheter
Device
Lead sponsor
Corewell Health East
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023
U.S. locations
1
States / cities
Royal Oak, Michigan
Source: ClinicalTrials.gov public record
Updated Sep 18, 2023 · Synced Oct 30, 2026, 4:53 AM EDT
Terminated No phase listed Observational Results available

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

NCT04753658
View directory record Official record
Conditions
Neuroblastoma
Interventions
lorlatinib
Drug
Lead sponsor
Pfizer
Industry
Eligibility
0 Years and older
Enrollment
15 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Sep 23, 2024 · Synced Oct 30, 2026, 4:53 AM EDT
Completed Not applicable Interventional Results available

Addressing Disparities in Neuromodulation for Rehabilitation: A Mixed Methods Approach to Optimize Access for Underrepresented Racial Minorities

NCT05896202
View directory record Official record
Conditions
Neuropathic Pain
Interventions
taVNS Video, Educational materials, TMS Video
Other
Lead sponsor
University of Miami
Other
Eligibility
18 Years to 80 Years
Enrollment
28 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024
U.S. locations
1
States / cities
Miami, Florida
Source: ClinicalTrials.gov public record
Updated Oct 27, 2025 · Synced Oct 30, 2026, 4:53 AM EDT
Enrolling by invitation Not applicable Interventional Accepts healthy volunteers

Great Saphenous Vein Anatomy at the Proximal Medial Thigh as a Potential Site for Rescue Venous Access

NCT04922606
View directory record Official record
Conditions
Anatomy of the GSV for Rescue Peripheral IV Access
Interventions
US ot the GSV
Diagnostic Test
Lead sponsor
Mayo Clinic
Other
Eligibility
Not listed
Enrollment
190 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2045
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jul 20, 2026 · Synced Oct 30, 2026, 4:53 AM EDT
Terminated No phase listed Observational

Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

NCT01280747
View directory record Official record
Conditions
Fibromyalgia, Painful Diabetic Peripheral Neuropathy
Interventions
prior authorization, no prior authorization
Other
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Eligibility
18 Years and older
Enrollment
42 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
17
States / cities
Beverly Hills, California • Lomita, California • Orange, California + 14 more
Source: ClinicalTrials.gov public record
Updated Jan 26, 2021 · Synced Oct 30, 2026, 4:53 AM EDT
Completed No phase listed Observational

Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

NCT02792764
View directory record Official record
Conditions
PORTs/Peripheral IVs Complication Rates
Interventions
Not listed
Lead sponsor
C. R. Bard
Industry
Eligibility
21 Years and older
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2015
U.S. locations
2
States / cities
Quincy, Illinois • Shreveport, Louisiana
Source: ClinicalTrials.gov public record
Updated Jun 8, 2016 · Synced Oct 30, 2026, 4:53 AM EDT